Comparing two liver-protecting supplements during tuberculosis treatment
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests whether two natural supplements—silymarin (milk thistle) and n-acetylcysteine—can protect the liver from damage caused by tuberculosis medications. If you qualify, you will receive one of these supplements along with your TB treatment to see which one helps prevent liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with tuberculosis and have not yet started TB treatment.
- You do not have a history of cancer, heart failure, or chronic liver disease.
- You do not have HIV, viral hepatitis, or conditions causing poor food absorption.
- You do not drink alcohol regularly.
- You have not had a stroke, COPD, asthma, chronic kidney disease, or a heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This study tests whether milk thistle (silymarin) or N-acetylcysteine, a common antioxidant supplement, can help prevent liver damage that can be caused by tuberculosis (TB) medications. If you are starting TB treatment, this trial may help protect your liver from side effects.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.